Sector consensus Charles River Laboratories International, Inc.

Equities

Market Closed - Nyse Other stock markets 20:00:02 13/03/2026 GMT			5-day change	1st Jan Change
155.46 ^USD	+1.83%		-10.89%	-22.07%

03-12	Locus Cell Co., Ltd. And Charles River Laboratories Sign Memorandum Of Understanding For Cell And Gene Therapy Collaboration	CI
03-10	Charles River Laboratories International, Inc. Presents at Barclays 28th Annual Global Healthcare Conference, Mar-10-2026 10:00 AM

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Objective/dr gap	Nbr of analysts
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	US$197.47	+29.35%	15
LONZA GROUP AG	CHF 675.78	+39.48%	23
BEONE MEDICINES AG	US$409.68	+43.6%	25
CELLTRION, INC.	₩253,958.33	+23.28%	24
IQVIA HOLDINGS INC.	US$236.19	+44.96%	21
REVOLUTION MEDICINES, INC.	US$129.35	+36.06%	20
ASCENDIS PHARMA A/S	US$247.03	+24.73%	16
MEDPACE HOLDINGS, INC.	US$489.69	+10.33%	13
EUROFINS SCIENTIFIC SE	€71.71	+16.29%	14
IONIS PHARMACEUTICALS, INC.	US$93.9	+29.8%	22
TEMPUS AI, INC.	US$77.93	+57.34%	14
ABIVAX	€108.72	+5.76%	6
QIAGEN N.V.	US$55.23	+34.32%	15
BIO-TECHNE CORPORATION	US$75.25	+46.2%	12
PRAXIS PRECISION MEDICINES, INC.	US$600.71	+98.01%	17
ICON PUBLIC LIMITED COMPANY	US$138.64	+42.27%	14
ARCELLX, INC.	US$111.07	-2.82%	14
HANGZHOU TIGERMED CONSULTING CO., LTD	CN¥67.77	+21.43%	14
PHARMARON BEIJING CO., LTD.	CN¥37.92	+33.65%	12
Average	13,567.49	+33.37%	16
Weighted average by Cap.	27,621.23	+34.49%	19